London, 13 August 2018 – Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable) announces that Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals, has launched Sterile Water for Injection, USP, 10mL.
Hikma’s Sterile Water for Injection, USP is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
IQVIA only captures a small proportion of Water for Injection, USP sales.
Riad Mechlaoui, Chief Executive Officer of Injectables said, “We are very pleased to be bringing Sterile Water for Injection to the market. Sterile water is the critical ingredient for reconstituting dry powders for injection. By launching Sterile Water for Injection, we hope to reduce the shortage of this product which is currently impacting hospitals across the US.”
This new product introduction expands Hikma’s broad offering of more than 90 products and further solidifies our position as one of the top 3 suppliers of generic injectable products to US hospitals.